Skye Bioscience Inc (SKYE)
1.8700 x 25 2.0800 x 8
Pre-market by (Cboe BZX)
2.0000 +0.0900 (+4.71%) 04/29/25 [NASDAQ]
1.8700 x 25 2.0800 x 8
Pre-market 1.8500 -0.1500 (-7.50%) 07:22 ET
for Wed, Apr 30th, 2025
Results
download Want to compare other data? Select Fields| Symbol | SKYE | BYSI | ARTV | ||
| Company | Skye Bioscience Inc | Beyondspring Inc | Artiva Biotherapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.85 | 1.5200 | 2.45 | ||
| High | 1.85 | 1.6194 | 2.47 | ||
| Low | 1.85 | 1.5100 | 2.40 | ||
| Last | 1.85 | 1.5500 | 2.45 | ||
| Change | -0.15 | -0.0200 | unch | ||
| % Change | -7.50% | -1.27% | unch | ||
| Volume | 1,972 | 15,000 | 154,400 | ||
| 20-Day Average Volume | 1,685,994 | 23,275 | 703,855 | ||
| Previous Close | 2.00 | 1.5700 | 2.45 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 1.55 | 1.3613 | 2.39 | ||
| 20-Day Raw Stochastic | 27.44% | 82.19% | 21.14% | ||
| 20-Day Relative Strength | 48.52% | 53.36% | 40.39% | ||
| Weighted Alpha | -71.42 | -34.99 | -81.97 | ||
| Today's Opinion | 88% Sell | 64% Sell | N/A | ||
| Previous Opinion | 88% Sell | 64% Sell | N/A | ||
| Last Month's Opinion | 100% Sell | 100% Sell | N/A | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.94% since 04/23/25 | +13.97% since 04/22/25 | unch since 04/22/25 | ||
| Low | 1.63 on 04/24/25 | 1.3100 on 04/23/25 | 2.27 on 04/28/25 | ||
| High | 2.11 on 04/29/25 | 1.6735 on 04/24/25 | 2.55 on 04/23/25 | ||
| 1-Month | |||||
| %Chg | -1.07% since 03/28/25 | +7.64% since 03/28/25 | -22.47% since 03/28/25 | ||
| Low | 1.14 on 04/08/25 | 0.9800 on 04/07/25 | 1.78 on 04/09/25 | ||
| High | 3.73 on 04/15/25 | 1.6735 on 04/24/25 | 4.95 on 04/07/25 | ||
| 3-Month | |||||
| %Chg | -50.67% since 01/30/25 | -10.41% since 01/29/25 | -54.46% since 01/29/25 | ||
| Low | 1.14 on 04/08/25 | 0.9800 on 04/07/25 | 1.78 on 04/09/25 | ||
| High | 4.25 on 01/31/25 | 1.8800 on 02/18/25 | 6.54 on 03/12/25 | ||
| 6-Month | |||||
| %Chg | -63.65% since 10/30/24 | -30.11% since 10/29/24 | -77.44% since 10/29/24 | ||
| Low | 1.14 on 04/08/25 | 0.9800 on 04/07/25 | 1.78 on 04/09/25 | ||
| High | 5.96 on 11/08/24 | 2.2800 on 11/27/24 | 15.49 on 11/07/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 61,950 | 62,490 | 59,689 | ||
| Shares Outstanding, K | 30,975 | 40,316 | 24,363 | ||
| Annual Sales | 0 | 0 | 250,000 | ||
| Annual Net Income | -26,570,000 | -11,120,000 | -65,370,000 | ||
| Last Quarter Sales | 0 | 338,000 | 0 | ||
| Last Quarter Net Income | -9,750,000 | -9,513,000 | -17,840,000 | ||
| 60-Month Beta | 1.88 | 0.21 | N/A | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.24 on 03/20/25 | N/A | -0.92 on 11/12/24 | ||
| Latest Earnings Date | 05/09/25 | 05/05/25 | 06/23/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||